Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical expulsive therapy using diuretics after shock wave lithotripsy of kidney stones
2024-510792-38-01Phase 3Withdrawn
- Sponsor
- Central Denmark Region
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of furosemide, tamsulosin, ibuprofen and acetaminophen in nephrolithiasis, ureterolithiasis and Renal colic (2 arms), sponsored by Central Denmark Region. Primary endpoint: Stone clearance at 4 weeks after last ESWL treatment. Planned start Feb 2025; status: withdrawn.
02
Drugs
furosemidetamsulosinibuprofenacetaminophen
03
Conditions
nephrolithiasisureterolithiasisRenal colic
Beyond the preview
Go deeper on 2024-510792-38-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510792-38-01.